CALL US: 1-352-733-0111

AMBITION: A Randomized, Multicenter Study of First-Line AMBrisentan and Tadalafil Combination Therapy in Subjects with Pulmonary Arterial Hypertension


The purpose of his study is to test how well the drugs ambrisentan and tadalafil work together to treat Pulmonary Arterial Hypertension (PAH) compared to ambrisentan or tadalafil alone. (Enrolling in Jacksonville, FL)


lung disease, pulmonary arterial hypertension

Principal Investigator

Abubakr Bajwa, CLIN AST PROF-JAX



Contact Information

Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at

Other Resources

  • Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams